0.0045
-0.00005 (-1.1%)
-0.00005 (-1.1%)
Upgrade to Real-Time
Market Closed
Volume | 10,000 |
|
|||||
News | - | ||||||
Day High | 0.0045 | Low High |
|||||
Day Low | 0.0045 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
RespireRx Pharmaceuticals Inc (PK) | RSPI | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.0045 | 0.0045 | 0.0045 | 0.00455 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
1 | 10,000 | $ 0.0045 | $ 45 | - | 0.0031 - 0.033 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
10:54:30 | 10,000 | $ 0.0045 | USD |
RespireRx Pharmaceuticals Inc (PK) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 538.17k | 119.59M | 77.95M | $ - | $ - | - | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
29.05k | $ - | - | - | - |
RespireRx Pharmaceuticals (PK) News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RSPI Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.0038 | 0.005 | 0.0034 | 0.0039826 | 306,448 | 0.0007 | 18.42% |
1 Month | 0.00385 | 0.005 | 0.0031 | 0.0037319 | 538,255 | 0.00065 | 16.88% |
3 Months | 0.00755 | 0.01 | 0.0031 | 0.0042995 | 557,755 | -0.00305 | -40.4% |
6 Months | 0.0169 | 0.019 | 0.0031 | 0.0062554 | 439,702 | -0.0124 | -73.37% |
1 Year | 0.0244 | 0.033 | 0.0031 | 0.0111088 | 341,270 | -0.0199 | -81.56% |
3 Years | 0.45 | 0.85 | 0.002 | 0.0086776 | 4,505,619 | -0.4455 | -99.0% |
5 Years | 1.25 | 2.90 | 0.002 | 0.0088795 | 2,964,374 | -1.25 | -99.64% |
RespireRx Pharmaceuticals (PK) Description
RespireRX Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery and development of novel drug therapies for the treatment of sleep apnea, ADHD, spinal cord injury and other neurological conditions. |